Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Third primary SARS-CoV-2 mRNA vaccines enhance antibody responses in most patients with haematological malignancies.
Cook LB, O'Dell G, Vourvou E, Palanicawandar R, Marks S, Milojkovic D, Apperley JF, Loaiza S, Claudiani S, Bua M, Hockings C, Macdonald D, Chaidos A, Pavlu J, Cooper N, Fidler S, Randell P, Innes AJ. Cook LB, et al. Among authors: palanicawandar r. Nat Commun. 2022 Nov 14;13(1):6922. doi: 10.1038/s41467-022-34657-z. Nat Commun. 2022. PMID: 36376307 Free PMC article.
E14a2 BCR-ABL1 transcript is associated with a higher rate of treatment-free remission in individuals with chronic myeloid leukemia after stopping tyrosine kinase inhibitor therapy.
Claudiani S, Apperley JF, Gale RP, Clark R, Szydlo R, Deplano S, Palanicawandar R, Khorashad J, Foroni L, Milojkovic D. Claudiani S, et al. Among authors: palanicawandar r. Haematologica. 2017 Aug;102(8):e297-e299. doi: 10.3324/haematol.2017.168740. Epub 2017 May 11. Haematologica. 2017. PMID: 28495914 Free PMC article. No abstract available.
Impact of route and adequacy of nutritional intake on outcomes of allogeneic haematopoietic cell transplantation for haematologic malignancies.
Beckerson J, Szydlo RM, Hickson M, Mactier CE, Innes AJ, Gabriel IH, Palanicawandar R, Kanfer EJ, Macdonald DH, Milojkovic D, Rahemtulla A, Chaidos A, Karadimitris A, Olavarria E, Apperley JF, Pavlu J. Beckerson J, et al. Among authors: palanicawandar r. Clin Nutr. 2019 Apr;38(2):738-744. doi: 10.1016/j.clnu.2018.03.008. Epub 2018 Mar 28. Clin Nutr. 2019. PMID: 29650256 Free article.
Complete remission with incomplete count recovery (CRi) prior to allogeneic HCT for acute myeloid leukaemia is associated with a high non-relapse mortality.
Innes AJ, Woolley P, Szydlo RM, Lozano S, Fernando F, Bansal D, Palanicawandar R, Milojkovic D, May PC, Nadal-Melsio E, Yebra-Fernandez E, Olavarria E, Apperley JF, Pavlů J. Innes AJ, et al. Among authors: palanicawandar r. Leukemia. 2020 Feb;34(2):667-670. doi: 10.1038/s41375-019-0572-z. Epub 2019 Sep 2. Leukemia. 2020. PMID: 31477799 Free article. No abstract available.
The role of ibrutinib in COVID-19 hyperinflammation: A case report.
Maynard S, Ros-Soto J, Chaidos A, Innes A, Paleja K, Mirvis E, Buti N, Sharp H, Palanicawandar R, Milojkovic D. Maynard S, et al. Among authors: palanicawandar r. Int J Infect Dis. 2021 Apr;105:274-276. doi: 10.1016/j.ijid.2021.02.056. Epub 2021 Feb 16. Int J Infect Dis. 2021. PMID: 33607304 Free PMC article.
Fecal Microbiota Transplant Mitigates Adverse Outcomes Seen in Patients Colonized With Multidrug-Resistant Organisms Undergoing Allogeneic Hematopoietic Cell Transplantation.
Innes AJ, Mullish BH, Ghani R, Szydlo RM, Apperley JF, Olavarria E, Palanicawandar R, Kanfer EJ, Milojkovic D, McDonald JAK, Brannigan ET, Thursz MR, Williams HRT, Davies FJ, Marchesi JR, Pavlů J. Innes AJ, et al. Among authors: palanicawandar r. Front Cell Infect Microbiol. 2021 Aug 27;11:684659. doi: 10.3389/fcimb.2021.684659. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34513724 Free PMC article.
Durable humoral responses after the second anti-SARS-CoV-2 vaccine dose in chronic myeloid leukaemia patients on tyrosine kinase inhibitors.
Claudiani S, Apperley JF, Parker EL, Marchesin F, Katsanovskaja K, Palanicawandar R, Innes AJ, Tedder RS, McClure MO, Milojkovic D. Claudiani S, et al. Among authors: palanicawandar r. Br J Haematol. 2022 Apr;197(1):e1-e4. doi: 10.1111/bjh.18001. Epub 2021 Dec 19. Br J Haematol. 2022. PMID: 34923623 No abstract available.
A retrospective analysis to evaluate if KIR B haplotype donors associate with a reduced risk of relapse in patients with haematological malignancies following haploidentical transplantation at the Blood and Bone Marrow Transplant Unit at Hammersmith Hospital ICHNHST.
Byrnes CP, Hastings A, Lacej I, Palanicawandar R, Olavarria E, Anand A. Byrnes CP, et al. Among authors: palanicawandar r. HLA. 2024 Jan;103(1):e15214. doi: 10.1111/tan.15214. Epub 2023 Sep 15. HLA. 2024. PMID: 37712429
14 results